ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
Price discrimination is an inequitable-sounding, but important, concept of charging different prices for the same product or service in different markets or segments of a market, usually based on consumers’ ability to pay.
During the 2016 ASCO Annual Meeting, a new award will be given out to recognize an extraordinary female leader in oncology and role model who has excelled as a mentor. I encourage you to nominate colleagues for this honor by January 29.
I had the opportunity to interview Dr. Cardinale Smith about Oncotalk, a communications course that she coordinates for oncology professionals and trainees.
There is plenty of research that proves what we intuitively know: a person who is well informed and invested in her treatment is more likely to seek out the resources she needs to cope with the physical and emotional side effects of rigorous treatment.
I like to consider myself an “evolved” clinician—one who believes in the patient’s voice, personally invested in shared decision-making, always ready to support my patient’s decisions, as long as I know it’s informed by the best data I have available, even when it is not the course I would want...
Participate in a Breakout Session on "Perspectives on Physician Aid in Dying" on Friday, January 22, at the 2016 Gastroinestinal Cancers Symposium, led by Chair Dr. George Fisher and speakers Dr. Lynne P Taylor and Dr. Kavitha Ramchandran.
This is a story of how small things really can make a big difference: a nurse anticipating a problem for a patient, a biomedical engineer open to collaboration, and a care provider taking an incremental approach to managing a patient's distress.
One of the most frequent questions I hear in my clinic is, “Are we making any progress?” or, “Is there anything new out there?” The answer is always yes, or more properly, YES!
ASCO staff and member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.
In November 2008, Michigan voters voted to legalize medical marijuana by a margin of 63% to 37%. At that time, I opposed the measure. Three years later, I developed a different perspective.
It is no accident that our Society’s member publication is titled ASCO Connection— its mission is to connect members to ASCO, ASCO to its members, and members to each other. After all, connection is why we join professional societies in the first place: to be a part of something...
The goal of the Poster Walk at the 2015 Palliative Care in Oncology Symposium was to promote group interaction surrounding poster presentations that deepens the conversation regarding the research, both for poster presenters and poster reviewers joining the walk.
She had been a patient for several years, and I still remember meeting her that first time: Her breast cancer was stage IV at diagnosis, already established in her bones; she was scared; she was in pain. Surgery was taken off the table and she was referred for medical therapy. We had discussed...
I was fortunate to begin my radiation oncology training on our Chairman’s service, working with lung cancer expert Dr. Ken Rosenzweig. At that time, one of my earliest clinical experiences was seeing a woman who had a history of early-stage lung cancer treated with radiation.
In 2012, in an attempt to answer the call to prioritize interventions, my colleagues and I, with support from the Asian Oncology Summit and Lancet Oncology, discussed and agreed upon a resource-stratified consensus on the management of colon cancer.
This last week I was traveling and experiencing the amazing sights of Georgia (the nation, not the state). Following my usual pattern, I used the Membership Directory and reached out to fellow ASCO members in Tbilisi.
The past year had been a tremendously exciting time to be an oncologist, and to be a lung cancer oncologist in particular. It seems we hardly have time to get used to one newly approved agent before another one becomes available.
Blogs
ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
No Results.
Pages
Advertisement